Results for tag: "Hycamtin"

Hycamtin (topotecan hydrochloride) is a chemotherapy drug used to treat small cell lung cancer (SCLC). It is a topoisomerase inhibitor, meaning it works by blocking the action of an enzyme that helps cancer cells divide and grow. Hycamtin is typically used in combination with other drugs, such as cisplatin, to treat SCLC. It is also used to treat ovarian cancer and cervical cancer. Hycamtin is manufactured by GlaxoSmithKline and is available in both oral and intravenous forms. It is approved for use in the United States, Europe, and other countries. The drug is typically prescribed by oncologists and is available through prescription only. The Hycamtin market is highly competitive, with several companies offering similar products. Companies such as Novartis, Pfizer, and AstraZeneca are all major players in the market. Other companies, such as Merck, Bristol-Myers Squibb, and Eli Lilly, also offer products in the same therapeutic area. In the Hycamtin market, GlaxoSmithKline is the leading manufacturer, followed by Novartis, Pfizer, AstraZeneca, Merck, Bristol-Myers Squibb, and Eli Lilly. Show Less Read more